Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $312.26 | 10 | 58.9% |
| Education | $184.57 | 7 | 34.8% |
| Gift | $33.70 | 1 | 6.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sirtex Medical Inc | $122.98 | 1 | $0 (2019) |
| Astellas Pharma US Inc | $98.95 | 1 | $0 (2020) |
| Elekta, Inc. | $91.36 | 1 | $0 (2019) |
| PFIZER INC. | $50.24 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $42.60 | 3 | $0 (2024) |
| Welch Allyn | $33.70 | 1 | $0 (2020) |
| Celgene Corporation | $18.58 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $17.33 | 1 | $0 (2020) |
| Karyopharm Therapeutics Inc. | $12.45 | 1 | $0 (2020) |
| Acrotech Biopharma LLC | $11.97 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.09 | 1 | Merck Sharp & Dohme LLC ($18.09) |
| 2023 | $13.86 | 1 | PFIZER INC. ($13.86) |
| 2021 | $23.89 | 2 | Acrotech Biopharma LLC ($11.97) |
| 2020 | $174.67 | 5 | Astellas Pharma US Inc ($98.95) |
| 2019 | $259.21 | 6 | Sirtex Medical Inc ($122.98) |
| 2018 | $11.41 | 1 | Novocure Inc. ($11.41) |
| 2017 | $29.40 | 2 | Celgene Corporation ($18.58) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Education | In-kind items and services | $18.09 | General |
| Category: ONCOLOGY | ||||||
| 04/10/2023 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $13.86 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 04/13/2021 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $11.97 | General |
| Category: ONCOLOGY | ||||||
| 11/17/2020 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Education | In-kind items and services | $12.45 | General |
| Category: Oncology | ||||||
| 08/17/2020 | Astellas Pharma US Inc | — | Education | In-kind items and services | $98.95 | General |
| 08/17/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $17.33 | General |
| Category: Oncology | ||||||
| 05/06/2020 | Welch Allyn | None (Device) | Gift | In-kind items and services | $33.70 | General |
| Category: Not Applicable | ||||||
| 03/12/2020 | PFIZER INC. | RUXIENCE (Biological) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2019 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $122.98 | General |
| Category: Interventional Oncology | ||||||
| 07/12/2019 | PFIZER INC. | MYLOTARG (Biological), DAURISMO | Food and Beverage | In-kind items and services | $12.31 | General |
| Category: ONCOLOGY | ||||||
| 06/02/2019 | Elekta, Inc. | Versa HD (Device), Mosaiq, Esteya | Food and Beverage | Cash or cash equivalent | $91.36 | General |
| Category: ELEKTA LINEAR ACCELERATOR | ||||||
| 02/15/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $7.04 | General |
| Category: Oncology | ||||||
| 02/13/2019 | PFIZER INC. | DAURISMO (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: ONCOLOGY | ||||||
| 05/08/2018 | Novocure Inc. | Oncology (Device) | Food and Beverage | Cash or cash equivalent | $11.41 | General |
| Category: Optune | ||||||
| 06/01/2017 | Celgene Corporation | Revlimid (Drug) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: Hematology / Oncology | ||||||
| 03/23/2017 | Merck Sharp & Dohme Corporation | EMEND (Drug), KEYTRUDA | Food and Beverage | In-kind items and services | $10.82 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 114 | 6,604 | 449,020 | $17.5M | $6.3M |
| 2022 | 110 | 6,650 | 457,366 | $17.0M | $6.1M |
| 2021 | 118 | 7,172 | 418,126 | $16.9M | $6.1M |
| 2020 | 111 | 6,281 | 338,215 | $12.1M | $4.3M |
All Medicare Procedures & Services
453 procedure records from CMS Medicare Utilization — Page 3 of 19
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9190 | Injection, fluorouracil, 500 mg | Office | 2023 | 47 | 1,736 | $10,416 | $3,258 | 31.3% |
| 96368 | Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | Office | 2023 | 66 | 195 | $10,725 | $2,970 | 27.7% |
| 96409 | Administration of chemotherapy into vein using push technique | Office | 2023 | 17 | 42 | $11,340 | $2,951 | 26.0% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 62 | 300 | $8,100 | $2,734 | 33.8% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 64 | 169 | $9,464 | $2,658 | 28.1% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 55 | 105 | $14,175 | $2,646 | 18.7% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 51 | 366 | $10,980 | $2,350 | 21.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $6,851 | $2,252 | 32.9% |
| J1756 | Injection, iron sucrose, 1 mg | Office | 2023 | 24 | 13,800 | $27,600 | $2,057 | 7.5% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 96 | 154 | $6,006 | $2,047 | 34.1% |
| 96374 | Injection of drug or substance into vein | Office | 2023 | 37 | 68 | $9,105 | $1,956 | 21.5% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Office | 2023 | 14 | 14 | $4,298 | $1,785 | 41.5% |
| J9171 | Injection, docetaxel, 1 mg | Office | 2023 | 18 | 3,789 | $18,945 | $1,749 | 9.2% |
| 96523 | Irrigation of implanted venous access drug delivery device | Office | 2023 | 26 | 88 | $6,688 | $1,726 | 25.8% |
| J9206 | Injection, irinotecan, 20 mg | Office | 2023 | 21 | 945 | $5,670 | $1,716 | 30.3% |
| J2997 | Injection, alteplase recombinant, 1 mg | Office | 2023 | 11 | 28 | $4,452 | $1,663 | 37.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $4,245 | $1,523 | 35.9% |
| J9263 | Injection, oxaliplatin, 0.5 mg | Office | 2023 | 31 | 26,629 | $26,629 | $1,490 | 5.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 19 | 24 | $3,600 | $1,483 | 41.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 20 | 20 | $2,280 | $1,435 | 62.9% |
| J9196 | Injection, gemcitabine hydrochloride (accord), not therapeutically equivalent to j9201, 200 mg | Office | 2023 | 18 | 441 | $5,292 | $1,316 | 24.9% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 84 | 11,735 | $11,735 | $1,294 | 11.0% |
| J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | Office | 2023 | 19 | 409 | $8,998 | $1,075 | 12.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 18 | 64 | $3,136 | $1,053 | 33.6% |
| 71250 | Ct scan of chest without contrast | Office | 2023 | 14 | 18 | $6,552 | $972.24 | 14.8% |
About Dr. Richard Cherny, M.D
Dr. Richard Cherny, M.D is a Hematology & Oncology healthcare provider based in East Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659351484.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Cherny, M.D has received a total of $530.53 in payments from pharmaceutical and medical device companies, with $18.09 received in 2024. These payments were reported across 18 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($312.26).
As a Medicare-enrolled provider, Cherny has provided services to 26,707 Medicare beneficiaries, totaling 1,662,727 services with total Medicare billing of $22.7M. Data is available for 4 years (2020–2023), covering 453 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location East Syracuse, NY
- Active Since 01/18/2006
- Last Updated 08/03/2018
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1659351484
Products in Payments
- SIR-Spheres Microspheres (Device) $122.98
- Versa HD (Device) $91.36
- None (Device) $33.70
- KEYTRUDA (Biological) $31.78
- Revlimid (Drug) $18.58
- OPDIVO (Biological) $17.33
- XTANDI (Drug) $13.86
- XPOVIO (Drug) $12.45
- MYLOTARG (Biological) $12.31
- RUXIENCE (Biological) $12.24
- BELEODAQ (Drug) $11.97
- DAURISMO (Drug) $11.83
- Oncology (Device) $11.41
- EMEND (Drug) $10.82
- Rubraca (Drug) $7.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in East Syracuse
Santosh Kumar, Md, MD
Hematology & Oncology — Payments: $31,857
Vinod Varki, M.d, M.D
Hematology & Oncology — Payments: $14,348
Dr. Tarek Sousou, Md, MD
Hematology & Oncology — Payments: $3,099
Santo Difino, M.d, M.D
Hematology & Oncology — Payments: $1,159
Benny Wong, M.d, M.D
Hematology & Oncology — Payments: $1,083
Aref Agheli, Md, MD
Hematology & Oncology — Payments: $666.07